Click Here for 5% Off Your First Aladdin Purchase!

Mestranol - ≥99%, high purity , Estrogen receptor alpha agonist, CAS No.72-33-3, Estrogen receptor alpha agonist

  • Moligand™
  • ≥99%
Item Number
M129878
Grouped product items
SKUSizeAvailabilityPrice Qty
M129878-50mg
50mg
In stock
$90.90
M129878-250mg
250mg
In stock
$406.90
M129878-1g
1g
In stock
$1,462.90
M129878-5g
5g
In stock
$6,579.90

Basic Description

Synonymsmestranol|72-33-3|Menophase|Norquen|Devocin|Ovastol|EE3ME|Ethynylestradiol 3-methyl ether|Mestranolum|3-Methoxyethynylestradiol|EE(sub3)ME|Ethynylestradiol methyl ether|3-Methylethynylestradiol|3-O-Methylethynylestradiol|Compound 33355|Inostral|3-Methylet
Specifications & PurityMoligand™, ≥99%
Storage TempStore at -20°C
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeAGONIST
Mechanism of actionEstrogen receptor alpha agonist
Product Description

Pharmacological estrogen molecule1,2,3

Product Properties

ALogP4

Associated Targets

CYP1A2 Tchem Cytochrome P450 1A2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD2 Tclin D(2) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD4 Tchem D(4) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CYP3A4 Tclin Cytochrome P450 3A4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ERBB2 Tclin Receptor tyrosine-protein kinase erbB-2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

GABRA1 Tclin Gamma-aminobutyric acid receptor subunit alpha-1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ELANE Tclin Neutrophil elastase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EGFR Tclin Epidermal growth factor receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AVPR1A Tclin Vasopressin V1a receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HMGCR Tclin 3-hydroxy-3-methylglutaryl-coenzyme A reductase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HRH1 Tclin Histamine H1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A3 Tclin Sodium-dependent dopamine transporter 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SLC6A4 Tclin Sodium-dependent serotonin transporter 2 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

SIGMAR1 Tclin Sigma non-opioid intracellular receptor 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PDE4D Tclin cAMP-specific 3',5'-cyclic phosphodiesterase 4D 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

PTGS1 Tclin Prostaglandin G/H synthase 1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CACNA1C Tclin Voltage-dependent L-type calcium channel subunit alpha-1C 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CA2 Tclin Carbonic anhydrase 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

DRD3 Tclin D(3) dopamine receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM3 Tclin Muscarinic acetylcholine receptor M3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

CHRM4 Tclin Muscarinic acetylcholine receptor M4 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2B Tclin Alpha-2B adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2C Tclin Alpha-2C adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2A Tclin 5-hydroxytryptamine receptor 2A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA2A Tclin Adenosine receptor A2a 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ACHE Tclin Acetylcholinesterase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA1B Tclin Alpha-1B adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA2A Tclin Alpha-2A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADRA1A Tclin Alpha-1A adrenergic receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AR Tclin Androgen receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

MAOA Tclin Amine oxidase [flavin-containing] A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

AKR1B1 Tclin Aldose reductase 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA1 Tclin Adenosine receptor A1 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR1A Tclin 5-hydroxytryptamine receptor 1A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

ADORA3 Tchem Adenosine receptor A3 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR3A Tclin 5-hydroxytryptamine receptor 3A 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR6 Tchem 5-hydroxytryptamine receptor 6 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

HTR2B Tclin 5-hydroxytryptamine receptor 2B 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

EDNRA Tclin Endothelin-1 receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

KCNH2 Tclin Potassium voltage-gated channel subfamily H member 2 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRD1 Tclin Delta-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRK1 Tclin Kappa-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

OPRM1 Tclin Mu-type opioid receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NOS2 Tchem Nitric oxide synthase, inducible 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

TACR1 Tclin Substance-P receptor 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

NOS1 Tchem Nitric oxide synthase, brain 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Names and Identifiers

IUPAC Name (8R,9S,13S,14S,17R)-17-ethynyl-3-methoxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-ol
INCHI InChI=1S/C21H26O2/c1-4-21(22)12-10-19-18-7-5-14-13-15(23-3)6-8-16(14)17(18)9-11-20(19,21)2/h1,6,8,13,17-19,22H,5,7,9-12H2,2-3H3/t17-,18-,19+,20+,21+/m1/s1
InChi Key IMSSROKUHAOUJS-MJCUULBUSA-N
Canonical SMILES CC12CCC3C(C1CCC2(C#C)O)CCC4=C3C=CC(=C4)OC
Isomeric SMILES C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)OC
WGK Germany 3
RTECS RC8960000
PubChem CID 6291
Molecular Weight 310.43
Beilstein 2625905

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

4 results found

Lot NumberCertificate TypeDateItem
I2220502Certificate of AnalysisJul 12, 2024 M129878
I2220503Certificate of AnalysisJul 12, 2024 M129878
I2220504Certificate of AnalysisJul 12, 2024 M129878
I2220538Certificate of AnalysisJul 12, 2024 M129878

Chemical and Physical Properties

SolubilityDMSO 15 mg/mL Water <1 mg/mL Ethanol 25 mg/mL
Specific Rotation[α][α]D:4° (C=2,Dioxane)
Melt Point(°C)151 °C

Safety and Hazards(GHS)

Pictogram(s) GHS08,   GHS07
Signal Danger
Hazard Statements

H315:Causes skin irritation

H319:Causes serious eye irritation

H351:Suspected of causing cancer

H302:Harmful if swallowed

H312:Harmful in contact with skin

H332:Harmful if inhaled

H360:May damage fertility or the unborn child

H362:May cause harm to breast-fed children

Precautionary Statements

P261:Avoid breathing dust/fume/gas/mist/vapors/spray.

P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing.

P280:Wear protective gloves/protective clothing/eye protection/face protection.

P302+P352:IF ON SKIN: wash with plenty of water.

P321:Specific treatment (see ... on this label).

P405:Store locked up.

P501:Dispose of contents/container to ...

P264:Wash hands [and …] thoroughly after handling.

P260:Do not breathe dust/fume/gas/mist/vapors/spray.

P271:Use only outdoors or in a well-ventilated area.

P270:Do not eat, drink or smoke when using this product.

P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing.

P362+P364:Take off contaminated clothing and wash it before reuse.

P330:Rinse mouth.

P263:Avoid contact during pregnancy/while nursing.

P203:Obtain, read and follow all safety instructions before use.

P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes.

P301+P317:IF SWALLOWED: Get medical help.

P318:if exposed or concerned, get medical advice.

P317:Get emergency medical help.

P337+P317:If eye irritation persists: Get medical help.

P332+P317:If skin irritation occurs: Get medical help.

WGK Germany 3
RTECS RC8960000

Related Documents

References

1. .  (1979-12-01)  Mestranol..  IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans,  21  (257-278).  [PMID:120834]
2. Thomas A Temes,Henrik Andersen,Daniel Gilberg,Matthias Bonerz.  (2002-07-26)  Determination of estrogens in sludge and sediments by liquid extraction and GC/MS/MS..  Analytical chemistry,  74  ((14)): (3498-3504).  [PMID:12139060]
3. Marie-Françoise Doursout,Jacques E Chelly.  (2002-11-19)  Effects of estrogen in the regulation of nitric oxide pathway during development of hypertension in rats..  Proceedings of the Western Pharmacology Society,  45  (49-52).  [PMID:12434525]
4. N G Coldham,R Horton,M F Byford,M J Sauer.  (2003-03-08)  A binary screening assay for pro-oestrogens in food: metabolic activation using hepatic microsomes and detection with oestrogen sensitive recombinant yeast cells..  Food additives and contaminants,  19  ((12)): (1138-1147).  [PMID:12623674]
5. .  (2003-10-17)  Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis..  Contraception,  68  ((3)): (159-176).  [PMID:14561536]
6. Hideki Mizunuma.  (2004-03-24)  [Treatment of osteoporosis with estrogen]..  Nihon rinsho. Japanese journal of clinical medicine,  62 Suppl 2  (397-403).  [PMID:15035159]
7. Stefanie Weber,Prisca Leuschner,Peter Kämpfer,Wolfgang Dott,Juliane Hollender.  (2004-08-04)  Degradation of estradiol and ethinyl estradiol by activated sludge and by a defined mixed culture..  Applied microbiology and biotechnology,  67  ((1)): (106-112).  [PMID:15290133]
8. Guillermo Marconi,Martín Vilela,Ramiro Quintana,Marco Diradourián,Edgardo Young,Carlos Sueldo.  (2004-12-14)  New observations on endometrial physiology after transcervical injection of methylene blue dye..  Fertility and sterility,  82  ((6)): (1700-1704).  [PMID:15589887]
9. Yuegang Zuo,Kai Zhang,Yiwei Deng.  (2005-11-26)  Occurrence and photochemical degradation of 17alpha-ethinylestradiol in Acushnet River Estuary..  Chemosphere,  63  ((9)): (1583-1590).  [PMID:16307786]
10. Rolf A Løvstad.  (2006-09-01)  A kinetic study on the lactoperoxidase catalyzed oxidation of estrogens..  Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine,  19  ((6)): (587-592).  [PMID:16944280]
11. Laura Canesi,Lucia Cecilia Lorusso,Caterina Ciacci,Michele Betti,Marco Rocchi,Giulio Pojana,Antonio Marcomini.  (2006-11-28)  Immunomodulation of Mytilus hemocytes by individual estrogenic chemicals and environmentally relevant mixtures of estrogens: in vitro and in vivo studies..  Aquatic toxicology (Amsterdam, Netherlands),  81  ((1)): (36-44).  [PMID:17126923]
12. Yuegang Zuo,Kai Zhang,Yuejuan Lin.  (2007-04-03)  Microwave-accelerated derivatization for the simultaneous gas chromatographic-mass spectrometric analysis of natural and synthetic estrogenic steroids..  Journal of chromatography. A,  1148  ((2)): (211-218).  [PMID:17399732]
13. Hongqi Li,Yanxi Song,Xianfu Peng.  (2008-02-08)  Improved synthesis of mestranol and ethinyl estradiol (EE) related degradation products as authentic references..  Steroids,  73  ((5)): (488-494).  [PMID:18255111]
14. Denis Fourches,Julie C Barnes,Nicola C Day,Paul Bradley,Jane Z Reed,Alexander Tropsha.  (2009-12-18)  Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species..  Chemical research in toxicology,  23  ((1)): (171-183).  [PMID:20014752]
15. Asier Vallejo,Aresatz Usobiaga,Irantzu Martinez-Arkarazo,Ailette Prieto,Nestor Etxebarria,Olatz Zuloaga,Luis A Fernández.  (2009-12-22)  Ultrasonic-assisted derivatization of estrogenic compounds in a cup horn booster and determination by GC-MS..  Journal of separation science,  33  ((1)): (104-111).  [PMID:20024927]
16. Nigel Greene,Lilia Fisk,Russell T Naven,Reine R Note,Mukesh L Patel,Dennis J Pelletier.  (2010-06-18)  Developing structure-activity relationships for the prediction of hepatotoxicity..  Chemical research in toxicology,  23  ((7)): (1215-1222).  [PMID:20553011]
17. Ji-Hong Hu,Li Wang,Wan-Shu Li,Da-Peng Dai,Jian-Ping Cai,Guo-Xin Hu.  (2015-05-01)  Effect of CYP2C9 Genetic Polymorphism in a Chinese Population on the Metabolism of Mestranol in vitro..  Pharmacology,  95  ((5-6)): (218-223).  [PMID:25924705]
18. J W Goldzieher,S A Brody.  (1990-12-01)  Pharmacokinetics of ethinyl estradiol and mestranol..  American journal of obstetrics and gynecology,  163  ((6 Pt 2)): (2114-2119).  [PMID:2256522]
19. R Pellegrini,E Seassaro.  (1969-09-01)  [Comparative study of the effect of ethinyl estradiol and mestranol. Clinical data from the literature]..  Quaderni di clinica ostetrica e ginecologica,  24  ((9)): (597-617).  [PMID:4926507]
20. Jun Mizutani,Muneyoshi Fukuoka,Shunji Tsubouchi,Takanobu Otsuka,Yuji Tono,Shigeki Shimizu,Nobuo Matsui.  (2002-08-27)  A rare case of lumbosacral meningioma: nondural attachment and possible enlargement by orally administered sex steroid..  Spine,  27  ((16)): (E377-E381).  [PMID:12195080]
21. Dennis R Doose,Shean-Sheng Wang,Mukund Padmanabhan,Stefan Schwabe,David Jacobs,Meir Bialer.  (2003-04-12)  Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects..  Epilepsia,  44  ((4)): (540-549).  [PMID:12681003]
22. Tom Kouki,Miho Okamoto,Shizuko Wada,Miki Kishitake,Korehito Yamanouchi.  (2004-12-21)  Suppressive effect of neonatal treatment with a phytoestrogen, coumestrol, on lordosis and estrous cycle in female rats..  Brain research bulletin,  64  ((5)): (449-454).  [PMID:15607833]
23. Tsuneo Takenaka,Yoshihiko Kanno,Hiromichi Suzuki.  (2005-01-13)  Judicious usage of estrogen/progesterone for angiodysplasia..  Artificial organs,  29  ((1)): (88-89).  [PMID:15644090]
24. Muhammad Iqbal Choudhary,Syed Ghulam Musharraf,Zafar Ali Siddiqui,Naik Tameen Khan,Rahat Azhar Ali,Atta Ur-Rahman.  (2005-08-05)  Microbial transformation of mestranol by Cunninghamella elegans..  Chemical & pharmaceutical bulletin,  53  ((8)): (1011-1013).  [PMID:16079537]
25. Jari Sinkkonen,Jaana Liimatainen,Maarit Karonen,Kirsti Wiinamäki,Patrik Eklund,Rainer Sjöholm,Kalevi Pihlaja.  (2007-04-25)  A sesquineolignan with a spirodienone structure from Pinus sylvestris L..  Angewandte Chemie (International ed. in English),  46  ((22)): (4148-4150).  [PMID:17455178]
26. Satoshi Kawamura,Akio Sakai,Tomomichi Endo,Masaki Maruta.  (2008-07-01)  Atypical depression as a premonitory symptom of migraine managed by an oral contraceptive..  Psychiatry and clinical neurosciences,  62  ((3)): (365-365).  [PMID:18588602]
27. Jules Schwartz,Thomas Hunt,William B Smith,Peggy Wong,Patrick Larson,Tami Crumley,Anish Mehta,Keith Gottesdiener,Nancy Agrawal.  (2009-05-16)  The effect of etoricoxib on the pharmacokinetics of oral contraceptives in healthy participants..  Journal of clinical pharmacology,  49  ((7)): (807-815).  [PMID:19443681]
28. Dóra Kovács,Zalán Kádár,Gergő Mótyán,Gyula Schneider,János Wölfling,István Zupkó,Eva Frank.  (2012-05-23)  Synthesis, characterization and biological evaluation of some novel 17-isoxazoles in the estrone series..  Steroids,  77  ((11)): (1075-1085).  [PMID:22613036]
29. Zhichao Liu,Qiang Shi,Don Ding,Reagan Kelly,Hong Fang,Weida Tong.  (2011-12-24)  Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)..  PLoS computational biology,  ((12)): (e1002310-e1002310).  [PMID:22194678]

Solution Calculators